GeoVax Labs Valuation
| GOVXW Stock | USD 0.13 0.00 0.00% |
GeoVax Labs seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of GeoVax Labs from evaluating the firm fundamentals such as Gross Profit of (21.58 M), return on equity of -3.62, and Return On Asset of -1.34 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GeoVax Labs' price fluctuation is out of control at this time. Calculation of the real value of GeoVax Labs is based on 3 months time horizon. Increasing GeoVax Labs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GeoVax stock is determined by what a typical buyer is willing to pay for full or partial control of GeoVax Labs. Since GeoVax Labs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeoVax Stock. However, GeoVax Labs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.13 | Real 0.11 | Hype 0.11 | Naive 0.12 |
The intrinsic value of GeoVax Labs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeoVax Labs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeoVax Labs helps investors to forecast how GeoVax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeoVax Labs more accurately as focusing exclusively on GeoVax Labs' fundamentals will not take into account other important factors: GeoVax Labs Total Value Analysis
GeoVax Labs is currently anticipated to have takeover price of 0 with market capitalization of 0, debt of 3.52 M, and cash on hands of 710.68 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the GeoVax Labs fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 3.52 M | 710.68 K |
GeoVax Labs Asset Utilization
One of the ways to look at asset utilization of GeoVax is to check how much profit was generated for every dollar of assets it reports. GeoVax Labs retains a negative application of resources of -1.34 (percent), losing $0.0134 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of GeoVax Labs shows how discouraging it operates for each dollar spent on its resources.GeoVax Labs Profitability Analysis
Net Loss for the year was (25.97 M) with loss before overhead, payroll, taxes, and interest of (21.58 M).About GeoVax Labs Valuation
Our relative valuation model uses a comparative analysis of GeoVax Labs. We calculate exposure to GeoVax Labs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GeoVax Labs's related companies.GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform in the United States and internationally. GeoVax Labs, Inc. was founded in 2001 and is based in Smyrna, Georgia. Geovax Labs is traded on NASDAQ Exchange in the United States.
GeoVax Labs Growth Indicators
Investing in growth stocks can be very risky. If the company such as GeoVax Labs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.5 M |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.